How to manage the renal patient with coronary heart disease: The agony and the ecstasy of opinion-based medicine

被引:73
作者
Herzog, CA [1 ]
机构
[1] Univ Minnesota, Dept Med, Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 10期
关键词
D O I
10.1097/01.ASN.0000087640.94746.47
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2556 / 2572
页数:17
相关论文
共 132 条
  • [11] Cardiac arrest in medical and dental practices - Implications for automated external defibrillators
    Becker, L
    Eisenberg, M
    Fahrenbruch, C
    Cobb, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (12) : 1509 - 1512
  • [12] Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction
    Berger, AK
    Duval, S
    Krumholz, HM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) : 201 - 208
  • [13] The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions
    Best, PJM
    Lennon, R
    Ting, HH
    Bell, MR
    Rihal, CS
    Holmes, DR
    Berger, PB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) : 1113 - 1119
  • [14] Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
    Best, PJM
    Lennon, R
    Gersh, BJ
    Ting, HH
    Rihal, CS
    Bell, MR
    Herzog, CA
    Holmes, DR
    Berger, PB
    [J]. AMERICAN HEART JOURNAL, 2003, 146 (02) : 345 - 350
  • [15] Impact of aortic stiffness on survival in end-stage renal disease
    Blacher, J
    Guerin, AP
    Pannier, B
    Marchais, SJ
    Safar, ME
    London, GM
    [J]. CIRCULATION, 1999, 99 (18) : 2434 - 2439
  • [16] Sudden and cardiac death rates in hemodialysis patients
    Bleyer, AJ
    Russell, GB
    Satko, SG
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (04) : 1553 - 1559
  • [17] Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
    Boaz, M
    Smetana, S
    Weinstein, T
    Matas, Z
    Gafter, U
    Iaina, A
    Knecht, A
    Weissgarten, Y
    Brunner, D
    Fainaru, M
    Green, MS
    [J]. LANCET, 2000, 356 (9237) : 1213 - 1218
  • [18] PERFUSION THALLIUM IMAGING OF TYPE-I DIABETES PATIENTS WITH END STAGE RENAL-DISEASE - COMPARISON OF ORAL AND INTRAVENOUS DIPYRIDAMOLE ADMINISTRATION
    BOUDREAU, RJ
    STRONY, JT
    DUCRET, RP
    KUNI, CC
    WANG, Y
    WILSON, RF
    SCHWARTZ, JS
    CASTANEDAZUNIGA, WR
    [J]. RADIOLOGY, 1990, 175 (01) : 103 - 105
  • [19] Acetylcysteine and contrast agent-associated nephrotoxicity
    Briguori, C
    Manganelli, F
    Scarpato, P
    Elia, PP
    Golia, B
    Riviezzo, G
    Lepore, S
    Librera, M
    Villari, B
    Colombo, A
    Ricciardelli, B
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (02) : 298 - 303
  • [20] Charra B, 1996, NEPHROL DIAL TRANSPL, V11, P16